Morganella Infections Clinical Presentation
- Author: James R Miller, MD; Chief Editor: Pranatharthi Haran Chandrasekar, MBBS, MD more...
Urinary tract infections
M morganii is commonly recovered from urine cultures in patients with long-term indwelling urinary catheters.
In a study of 135 consecutive patients with symptomatic, complicated, multidrug-resistant urinary tract infections, nearly 10% were infected with M morganii.
Like Proteus species, M morganii has properties that enhance its ability to infect the urinary tract; these include motility and the ability to produce urease.
Urolithiasis is associated with both genera. Members of the tribe Proteeae account for approximately 50% of cases of urolithiasis associated with urinary tract infections in children.
M morganii has been associated with perinatal infection. Four cases of chorioamnionitis and one case of postpartum endometritis have been reported, and each case involved immunocompetent women.[4, 5]
Three of the women had received parenteral treatment with ampicillin prior to delivery.
In 2 of the pregnancies, the neonates were not infected.
A third neonate developed early-onset sepsis and M morganii bacteremia. He was treated successfully with 10 days of cefotaxime and gentamicin. A fourth neonate, born at 24 weeks' gestation, died within the first 38 hours of life. M morganii was recovered from this neonate's blood, pleural fluid, and peritoneal fluid cultures.
The fifth case occurred in a mother who had repeated exposures to beta-lactam antibiotics in the months prior to delivery for rheumatic fever prophylaxis and pharyngitis and then had intrapartum ampicillin for chorioamnionitis. Her neonate, born at 35 weeks' gestation, was treated empirically with intravenous ampicillin and gentamicin immediately after delivery, but he developed respiratory distress and petechial and purpuric skin lesions on the second day of life. A chest radiograph revealed a lobar infiltrate. Blood culture findings were positive for M morganii that was resistant to ampicillin and susceptible to cefotaxime and gentamicin. He recovered following a 14-day course of cefotaxime and gentamicin. His mother remained febrile after delivery, with evidence of endometritis and subsequent M morganii urinary tract infection. Her isolate was resistant to ampicillin and gentamicin and was treated successfully with imipenem-cilastatin.
Two cases of early-onset neonatal sepsis in the absence of maternal infection have been reported. Both involved 32-week–premature neonates born to mothers who had received dexamethasone and ampicillin prior to delivery. Both neonates were treated with cefotaxime and amikacin. One neonate's sepsis responded to treatment; the other neonate died from M morganii infection.
Late-onset neonatal infection
Late-onset neonatal infection has been reported in 2 neonates: (1) a neonate born at term who presented on the 11th day of life with fever, irritability, and M morganii bacteremia and (2) a 15-day-old neonate with M morganii meningitis and brain abscess.
Four cases of M morganii septic arthritis have been reported in adults. All presented as chronic indolent infections. In contrast to the aggressive and destructive joint disease associated with Proteus mirabilis septic arthritis, the cases of M morganii arthritis were remarkable for their benign clinical presentations and lack of joint damage despite a prolonged course.[8, 9, 10]
M morganii is commonly found in the mouths of snakes. As a result, it is one of the organisms recovered most often from snakebite infections. Jorge (1994) recovered M morganii from 57% of abscesses occurring at the site of Bothrops (ie, the American Lanceheads) bites.
M morganii produces the enzyme histidine decarboxylase, which reacts with histidine, a free amino acid present in the muscle of some species of fin fish, including tunas, mahimahi, sardines, and mackerel. When these fish are improperly stored, spoilage from M morganii may cause the decarboxylation of histidine into histamine. Scombroid poisoning, an anaphylacticlike clinical syndrome, is caused by ingestion of the histamine-containing fish.[12, 13]
Infections in people with AIDS
In a retrospective review of 73 patients with M morganii bacteremia in Taiwan, 70% cases were community acquired and 45% were associated with polymicrobial bacteremia. The most common portals of entry were the urinary tract and hepatobiliary tract. Polymicrobial infection was most commonly associated with hepatobiliary disease. The overall mortality rate was 38%. The most important risk factor for mortality was inappropriate antibiotic therapy.
CNS infections are rare. Six adult cases have been reported, including 3 cases of meningitis and 3 cases of brain abscess. The most common presentation was fever and altered mental status. Two of the patients with meningitis died. Two patients with brain abscess survived, one with long-term neurological sequelae.
Physical findings are similar to those of other gram-negative infections.
Ecthyma gangrenosum–like eruptions and hemorrhagic bullae have been associated with M morganii sepsis.
One 15-year-old girl with recurrent episodes of Henoch-Schönlein purpura was found to have a tuboovarian abscess caused by M morganii. Treatment of the infection resulted in complete remission of the vasculitis.
Risk factors for M morganii infection include the following:
Prior exposure to ampicillin and other beta-lactam antibiotics
Abscesses or soft tissue infections following snakebite
Tucci V, Isenberg HD. Hospital cluster epidemic with Morganella morganii. J Clin Microbiol. 1981 Nov. 14(5):563-6. [Medline].
McDermott C, Mylotte JM. Morganella morganii: epidemiology of bacteremic disease. Infect Control. 1984 Mar. 5(3):131-7. [Medline].
Kwon OY, Lee JS, Choi HS, Hong HP, Ko YG. Infected abdominal aortic aneurysm due to Morganella morganii: CT findings. Abdom Imaging. 2011 Feb. 36(1):83-5. [Medline].
Johnson JR, Feingold M. Case of chorioamnionitis in an immunocompetent woman caused by Morganella morganii. J Matern Fetal Med. 1998 Jan-Feb. 7(1):13-4. [Medline].
Ranu SS, Valencia GB, Piecuch S. Fatal early onset infection in an extremely low birth weight infant due to Morganella morganii. J Perinatol. 1999 Oct-Nov. 19(7):533-5. [Medline].
Verboon-Maciolek M, Vandertop WP, Peters AC, et al. Neonatal brain abscess caused by Morganella morgagni. Clin Infect Dis. 1995 Feb. 20(2):471. [Medline].
Gautam V, Gupta V, Joshi RM, et al. Morganella morganii-associated arthritis in a diabetic patient. J Clin Microbiol. 2003 Jul. 41(7):3451. [Medline].
Katz LM, Lewis RJ, Borenstein DG. Successful joint arthroplasty following Proteus morganii (Morganella morganii) septic arthritis: a four-year study. Arthritis Rheum. 1987 May. 30(5):583-5. [Medline].
Schonwetter RS, Orson FM. Chronic Morganella morganii arthritis in an elderly patient. J Clin Microbiol. 1988 Jul. 26(7):1414-5. [Medline].
Jorge MT, Ribeiro LA, da Silva ML, et al. Microbiological studies of abscesses complicating Bothrops snakebite in humans: a prospective study. Toxicon. 1994 Jun. 32(6):743-8. [Medline].
Lopez-Sabater EI, Rodriguez-Jerez JJ, Hernandez-Herrero M, et al. Incidence of histamine-forming bacteria and histamine content in scombroid fish species from retail markets in the Barcelona area. Int J Food Microbiol. 1996 Jan. 28(3):411-8. [Medline].
Otwell WS. Scombroid Poisoning. US Food and Drug Administration, Sea Grant Extension Fact Sheet. 1995. [Full Text].
Mastroianni A, Coronado O, Chiodo F. Morganella morganii meningitis in a patient with AIDS. J Infect. 1994 Nov. 29(3):356-7. [Medline].
Arranz-Caso JA, Cuadrado-Gomez LM, Romanik-Cabrera J, et al. Pyomyositis caused by Morganella morganii in a patient with AIDS. Clin Infect Dis. 1996 Feb. 22(2):372-3. [Medline].
Chen HW, Lin TY. Tumor abscess formation caused by Morganella morganii complicated with bacteremia in a patient with gastrointestinal stromal tumor. Clin Res Hepatol Gastroenterol. 2011 Sep 14. [Medline].
Abdalla J, Saad M, Samnani I, et al. Central nervous system infection caused by Morganella morganii. Am J Med Sci. 2006 Jan. 331(1):44-7. [Medline].
Pomeranz A, Korzets Z, Eliakim A, et al. Relapsing Henoch-Schonlein purpura associated with a tubo-ovarian abscess due to Morganella morganii. Am J Nephrol. 1997. 17(5):471-3. [Medline].
Choi SH, Lee JE, Park SJ, et al. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use. Antimicrob Agents Chemother. 2008 Mar. 52(3):995-1000. [Medline].
Bagel J, Grossman ME. Hemorrhagic bullae associated with Morganella morganii septicemia. J Am Acad Dermatol. 1985 Mar. 12(3):575-6. [Medline].
Bensman A, Roubach L, Allouch G, et al. Urolithiasis in children. Presenting signs, etiology, bacteriology and localisation. Acta Paediatr Scand. 1983 Nov. 72(6):879-83. [Medline].
Casanova-Roman M, Sanchez-Porto A, Casanova-Bellido M. Early-onset neonatal sepsis caused by vertical transmission of Morganella morganii. Scand J Infect Dis. 2002. 34(7):534-5. [Medline].
Cox CE. Aztreonam therapy for complicated urinary tract infections caused by multidrug-resistant bacteria. Rev Infect Dis. 1985 Nov-Dec. 7 Suppl 4:S767-71. [Medline].
Cunningham ET Jr, Whitcher JP, Kim RY. Morganella morganii postoperative endophthalmitis. Br J Ophthalmol. 1997 Feb. 81(2):170-1. [Medline].
Del Pozo J, Garcia-Silva J, Almagro M, et al. Ecthyma gangrenosum-like eruption associated with Morganella morganii infection. Br J Dermatol. 1998 Sep. 139(3):520-1. [Medline].
Gebhart-Mueller Y, Mueller P, Nixon B. Unusual case of postoperative infection caused by Morganella morganii. J Foot Ankle Surg. 1998 Mar-Apr. 37(2):145-7. [Medline].
Isobe H, Motomura K, Kotou K, et al. Spontaneous bacterial empyema and peritonitis caused by Morganella morganii. J Clin Gastroenterol. 1994 Jan. 18(1):87-8. [Medline].
Lee IK, Liu JW. Clinical characteristics and risk factors for mortality in Morganella morganii bacteremia. J Microbiol Immunol Infect. 2006 Aug. 39(4):328-34. [Medline].
Müller HE. Occurrence and pathogenic role of Morganella-Proteus-Providencia group bacteria in human feces. J Clin Microbiol. 1986 Feb. 23(2):404-5. [Medline].
O'Hara CM, Brenner FW, Miller JM. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev. 2000 Oct. 13(4):534-46. [Medline].
Piccolomini R, Cellini L, Allocati N, et al. Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections. Antimicrob Agents Chemother. 1987 Oct. 31(10):1644-7. [Medline].
Rowen JL, Lopez SM. Morganella morganii early onset sepsis. Pediatr Infect Dis J. 1998 Dec. 17(12):1176-7. [Medline].
Salen PN, Eppes S. Morganella morganii: a newly reported, rare cause of neonatal sepsis. Acad Emerg Med. 1997 Jul. 4(7):711-4. [Medline].
Samonis G, Anatoliotaki M, Apostolakou H, et al. Fatal septicemia and meningitis due to Morganella morganii in a patient with Hodgkin's disease. Scand J Infect Dis. 2001. 33(7):553-5. [Medline].
Stock I, Wiedemann B. Identification and natural antibiotic susceptibility of Morganella morganii. Diagn Microbiol Infect Dis. 1998 Mar. 30(3):153-65. [Medline].
Williams EW, Hawkey PM, Penner JL, et al. Serious nosocomial infection caused by Morganella morganii and Proteus mirabilis in a cardiac surgery unit. J Clin Microbiol. 1983 Jul. 18(1):5-9. [Medline].
Vinogradov E, Nash JH, Foote S, Young NM. The structure of the Morganella morganii lipopolysaccharide core region and identification of its genomic loci. Carbohydr Res. 2015 Jan 30. 402:232-5. [Medline].